Regarding the different clinical stages of RA, our results indicate that RBCs from early-standing RA patients differ significantly (p < 0.05) from RBCs from long-standing RA patients in terms of survivin expression and 3-NT content. This evidence concerns the gene BIRC5 and rheumatoid arthritis.